the paste without CPP-ACP
Phase 2Small molecule
the paste without CPP-ACP is one of 10 small molecule programs targeting Dental Caries. It is currently in Phase 2.
1
Indications
1
Total Trials
0
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
15 competitors in Dental Caries
#DrugCompanyPhaseTrials
1Peridex
DDexcel Pharma Technologies Ltd.
Approved
Mycostatin
GGood Molecules, LLC
Approved
Betadine
BBecton, Dickinson and Company
Approved
Zocor
OOrganon and Co
Approved
Peridex
MMedline Industries
Phase 3
Fluoride Varnish
TThe University of Hong Kong
Approved
Calcium Hydroxide
MMansoura University
Phase 2
the paste without CPP-ACP
TThammasat University
Phase 2
Chlorhexidine Digluconate
GSKPreclinical
Vancomycin Hydrochloride
WWake Forest University Health Sciences
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for the paste without CPP-ACP. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- TThammasat University